Results 31 to 40 of about 395,113 (303)

Withania somnifera Root Extract Inhibits Mammary Cancer Metastasis and Epithelial to Mesenchymal Transition [PDF]

open access: yes, 2013
Though clinicians can predict which patients are at risk for developing metastases, traditional therapies often prove ineffective and metastatic disease is the primary cause of cancer patient death; therefore, there is a need to develop anti-metastatic ...
Garcia, Anapatricia   +7 more
core   +10 more sources

Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma [PDF]

open access: yes, 2012
Basal cell carcinoma (BCC) of the skin is the most common type of cancer, and accounts for up to 40% of all cancers in the United States with a growing incidence rate in the last decades in all developed countries.
CUCCHI, DANILO   +3 more
core   +3 more sources

The molecular basis for ethnic variation and histological subtype differences in prostate cancer. [PDF]

open access: yes, 2013
Prostate cancer is a common malignancy among men in Western countries. Recently the morbidity and mortality of prostate cancer increase dramatically in several oriental countries including China.
Goldstein, Andrew S   +2 more
core   +1 more source

A lobulated mass on the upper back with prominent vasculature: A giant basal cell carcinoma

open access: yesDermatology Reports, 2021
Basal cell carcinoma (BCC) is characterized by slow but locally invasive growth. Although there is low metastatic potential, if not treated early, these skin cancers can lead to significant morbidity and mortality.
Elysha M. Kolitz   +3 more
doaj   +1 more source

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. [PDF]

open access: yes, 2016
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and safety of vismodegib in these patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC) in the ERIVANCE BCC
Arron, Sarah   +8 more
core   +2 more sources

Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast [PDF]

open access: yes, 2015
Background: Metastases to the breast from extramammary malignancies are very rare, and ruling out the diagnosis of primary breast tumor is important in order to decide on clinical management and predict prognosis.
Derme, Martina   +5 more
core   +2 more sources

Eccrine porocarcinoma of the head: An important differential diagnosis in the elderly patient [PDF]

open access: yes, 2008
Background: Eccrine porocarcinoma is a rare malignant tumor of the sweat gland, characterized by a broad spectrum of clinicopathologic presentations. Surprisingly, unlike its benign counterpart eccrine poroma, eccrine porocarcinoma is seldom found in ...
Akiyoshi E   +25 more
core   +1 more source

Key signalling nodes in mammary gland development and cancer: the snail1-twist1 conspiracy in malignant breast cancer progression [PDF]

open access: yes, 2010
Breast cancer is the most common cancer among women, and despite significant advances in diagnosing and treating it, metastatic spread of cancer cells results in a high mortality rate. Epithelial-to-mesenchymal transition (EMT) is an embryonic program in
Foubert, Ellen   +2 more
core   +2 more sources

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

open access: yesJournal for ImmunoTherapy of Cancer, 2017
Monoclonal antibodies that block immune regulatory proteins such as programmed death-1 (PD-1) have demonstrated remarkable efficacy in controlling the growth of multiple tumor types.
Megan Schollenberger   +8 more
doaj   +1 more source

Cutaneous Metastatic Undifferentiated Carcinoma to the Mandibular Gingiva: A Rare Case Report

open access: yesJournal of Dental School, 2023
Objectives Metastasis to the oral cavity is a rare phenomenon. Basal cell carcinoma (BCC) is the most common skin malignancy, followed by squamous cell carcinoma (SCC) and melanoma.
Dr.Saede Atarbashi Moghadam   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy